secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pulmonx Corp (LUNG)
CIK:        0001127537
Form:       8-K
Filed at:   2025-10-27T23:59:59+00:00
Accession:  0001127537-25-000052
Event type: leadership
Sentiment:  negative
Materiality: 0.85
Item codes: 2.02, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pulmonx reappoints Glen French as CEO and Derrick Sung as COO/CFO; Q3 preliminary revenue ~$21.5M
--------------------------------------------------------------------------------

- Glen French (former CEO 2014-2024) reappointed President and CEO; Derrick Sung (former CFO) appointed COO and CFO effective Nov 3, 2025.
- Steve Williamson and Mehul Joshi resigned as CEO and CFO; each will serve as advisors through Dec 1, 2025; departures not due to any disagreement.
- Preliminary Q3 2025 revenue expected approximately $21.5M; full results and earnings call rescheduled to Nov 12, 2025.
- Williamson receives $600K severance plus COBRA; Joshi receives $347,625 plus COBRA as separation compensation.
- French receives $625K base salary, 100% target bonus, RSU for 1.2M shares, and PSU for 800K shares with $4.00 stock price performance condition.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1127537/000112753725000052/0001127537-25-000052-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1127537/000112753725000052/lung-20251021.htm
  HTML page:      https://secwatch.observer/filing/0001127537-25-000052

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer